Carlisle surgery bus cut exposes the transport gap behind missed appointments
A council decision to end the DR1 bus service to Carlisle Healthcare’s South surgery has triggered frustration from clinicians and local residents who had hoped the route would improve access to care for patients struggling to reach appointments. The service, introduced in January after a public petition and funded from part of a £3.5m government allocation, will stop at the end of December after Cumberland Council judged the passenger numbers too low to justify continued support.
For a health service, transport is not a side issue. It is often the difference between attendance and non-attendance, especially for older people, disabled patients and anyone without access to a car. The route was designed to connect Carlisle city centre with the Locke Road surgery, a location that some residents found difficult to reach by existing public transport. When the final decision rests on passenger counts alone, the result can look neat on a spreadsheet while remaining awkward at the bedside.
Dr Robert Westgate, a GP partner at Carlisle Healthcare, said the surgery had hoped the bus would become “an increasingly useful option for patients.” He said the practice was “very disappointed” that the service is ending. The provider runs three surgeries in Carlisle and cares for more than 40,000 patients across its sites, according to NHS data, so changes in local transport can affect a substantial patient base even if the numbers using a single route appear modest.
Low ridership, high subsidy, and the limits of a protected route
Cumberland Council said the DR1 carried an average of 312 people a month, a level it described as unsustainable because the service cost more than £20 per passenger. Karl Melville, the council’s assistant director of highways and transport, said the decision was made “with a very heavy heart” and that the need to get people to appointments had been considered. He pointed to the current fare cap, noting that £3 is the maximum charge on any bus journey, soon to fall to £2 next year, which makes a publicly funded subsidy of well over £20 a ticket difficult to defend politically and financially.
There is a clear tension here between public transport economics and healthcare access. A lightly used route can still matter clinically if it carries the exact passengers most likely to miss appointments without it. Elderly residents, people with mobility problems and patients living with chronic disease do not always generate high daily volumes, but they often have the least flexibility to adapt when a route disappears. Low ridership may reflect poor timing, awkward routing, weak publicity or simple hesitation from patients who need reassurance before changing routine travel habits.
One sentence captures the problem bluntly: the bus was too lightly used to survive, yet it was introduced because the existing network was not enough.
Local opposition says the service was never designed around real patient need
The route drew more than 1,000 signatures on a petition last year, a signal that the issue cut beyond routine transport complaints. Robert Betton, the councillor who launched the petition, said he was “absolutely appalled” by the decision and argued that the community had been let down. He said he had pressed for the service to run through Botcherby and Harraby, but the council said that would not be possible because it would compete with existing Stagecoach routes.
That constraint matters because it shows how public transport planning can become trapped between competing objectives. A route designed to support healthcare access must also fit within commercial bus boundaries, yet those boundaries may not line up with where the patients actually live. If the route avoids certain neighbourhoods in order not to overlap with commercial services, the people who most need it may remain excluded. Betton said he wanted a “genuine partnership” between agencies to support elderly and disabled residents and those without a car, and that remains the central unresolved issue: whether transport policy can be made to follow healthcare demand rather than simply protect existing route maps.
The criticism from local campaigners is not only that the service ended, but that it was constrained from the start. Betton said the bus had been “set up to fail,” arguing that local knowledge was ignored and that the service was later judged by numbers that were never likely to be strong if the route did not adequately reach the communities it was meant to serve.
Patient access depends on more than a stop outside the surgery
Melville said there are two other services running nearby, leaving a short walk from the bus stop to the surgery. In urban planning terms, that may sound manageable. In clinical practice, it is a very different calculation. A short walk is not short for someone with arthritis, breathlessness, frailty, balance problems or the burden of carrying a child and paperwork while trying to arrive on time. For some patients, a route that ends “nearby” still fails if it does not solve the last few hundred metres.
Westgate said the practice recognised the effort that had gone into establishing the DR1 service. The tone is measured, but the implication is clear: once a transport link is removed, the surgery does not simply inherit the problem without consequence. Missed appointments, delayed reviews and avoidable cancellations tend to hit patients with the fewest resources hardest. Those harms are diffuse and rarely show up in the monthly passenger totals that determine whether a route survives.
Cumberland Council confirmed that the DR1 is one of six services losing council support in the new year, even as it continues funding worth £2.9m for 13 services it either introduced or enhanced over the last 12 months. The list includes links such as the 600 service between the Cumberland Infirmary in Carlisle and West Cumberland Hospital in Whitehaven, the C123 Cockermouth town service and the 7 Barrow to Millom bus. The council is clearly still willing to fund some routes, but only where the balance of usage, need and network fit appears stronger.
The unresolved question is how to design transport that serves clinical access without relying on patient volume alone as the main measure of value. In communities where healthcare sites are spread out and public transport choices are thin, the right bus route can function as part of the care pathway. Without that alignment, the burden shifts back to patients, and the people most likely to struggle are often the ones least able to absorb another barrier to attending care.